Background: Potassium-chloride cotransporters (KCCs) belong to the SLC12A gene family and are responsible for the symport transport of K+ and Cl- ions in an electroneutral manner. There are four KCCs isoforms (KCC1-4) playing important roles in numerous physiological processes, from cell volume regulation to transepithelial solute transport, intracellular ion homeostasis and regulation of GABA neurotransmission. This activity is regulated by phosphorylation and dephosphorylation mechanisms by the WNK-SPAK/OSR1 kinases and PP1 phosphatase. Cryocryo-EM structural determination of KCCs have deepened our understanding of their molecular basis and transport function, including architecture, ion binding sites, and coupled ion transport. Either for Na or K transport, specific and conserved amino acids involved in ion binding, stabilization and interaction have been identified. In the present study, we generated Na binding sites in human KCCs to determine whether regulation of their activity and phospho/ dephosphorylation is modified and whether new transport properties can be induced. Methods: HEK-293 cells were transfected with human wild type (WT) KCC2 or KCC4 and ion binding site mutants: KCC2 Q132L-F135W-S517A-G520S-A521S (LWASS), and KCC4 C516S- G517S (CGSS). KCCs phosphorylation status in response to isotonic and hypotonic conditions was evaluated by immunoblot analysis of regulatory phosphorylation sites pThr1030/980 and pThr929/926. In parallel, phosphorylation status of SPAK/OSR1 activating regulatory site pSer373/pSer325 were analyzed under the same conditions. Results: After osmotic stimulation, phospho and dephosphorylation patterns of KCC2 LWASS and KCC4 CGSS mutants were not the same as their WT controls. As expected under isotonic high K stimuli, KCCs are inactive (phosphorylated) while ion binding mutants showed no phosphorylation under this conditions, implying constitutive activity. Total protein expression of both mutants showed equal levels as their WT counterparts, suggesting that the changes observed are due to modified ion binding sites and transport properties regulation. Standard SPAK kinase phosphorylation was observed. Conclusions: Ion binding site mutations might induce conformational changes that alter KCCs osmotic regulation. Transport assays and molecular modeling are needed to support this findings. This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
Alejo et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: